Latest Autoimmunity Stories

Mediaplanet's awareness campaign aims to unite community and improve the search for both answers and a cure. New York, NY (PRWEB) June 12, 2013 Autoimmune Awareness campaign hits newsstands- We go to extreme measures to protect ourselves from harm. But what do you do when your body is your own worst enemy? For the 50 million Americans suffering from autoimmune disease this nightmare is a daily reality. Despite autoimmune disease affecting more people than cancer and heart disease...

Multinational, Multidisciplinary Expert Panel Reveals Survey Findings, Asks Patients to Take Pledge as Part of RA: Join the Fight, an AbbVie Global Initiative MADRID, June 11, 2013 /PRNewswire/ -- RA: Join the Fight today presented at a launch event in Madrid the findings from the largest global rheumatoid arthritis (RA) patient survey, which included 10,171 patients across 42 countries. Findings show that while a majority of RA patients (74 percent) say they know a great deal or a...

Lee Rannals for redOrbit.com – Your Universe Online Northwestern Medicine researchers say they have discovered a big breakthrough that could help people suffering from multiple sclerosis (MS). The researchers completed the first phase of a clinical trial for the first treatment to reset the immune system of MS patients. They found that the patients showed the therapy was safe and dramatically reduced their immune systems' reactivity to myelin by 50 to 75 percent. In MS, the immune...

Raises Thousands to Support Science and Service for NYC Lupus Community NEW YORK, June 5, 2013 /PRNewswire/ -- The S.L.E. Lupus Foundation's Young Leaders Committee brought together lupus advocates, friends, family members, and coworkers for the highly successful ninth annual "Night for the Fight." With more than 250 guests, New York's young professionals raised more this year than ever to help achieve the Foundation's mission to support novel research and patient services, while...

When DNA that turns up in the wrong place in mammalian cells, the innate immune system reacts by secreting interferons. The structure and mode of action of the enzyme that mediates this response have now been elucidated. In animal cells, DNA molecules are normally restricted to the cell nucleus and the mitochondria. When DNA appears outside these organelles – in the so-called cytosol - it most probably originates from a bacterial pathogen or a DNA virus. This is why cytosolic DNA...

PORTLAND, Ore., June 4, 2013 /PRNewswire-USNewswire/ -- Six of the top scientists studying psoriasis--the most common autoimmune disease in the country, affecting 7.5 million Americans--and psoriatic arthritis, an inflammatory joint and tendon disease affecting up to 30 percent of people with psoriasis, received National Psoriasis Foundation (NPF) research grants totaling $450,000 for projects that aim to discover new treatments and a cure for these chronic diseases. (Photo:...

HAYWARD, Calif., May 31, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, President and Chief Executive Officer, and Dr. Colin Hislop, Senior Vice President and Chief Medical Officer, will present a corporate update at the 2013 Annual Jefferies Global Healthcare Conference. Anthera will present on at 1:30PM ET, June 6(th)...

Treatment for Autoimmune and Other Diseases AUSTIN, Texas, May 31, 2013 /PRNewswire/ -- XBiotech, a privately held biotechnology company, announced today its development of a novel True Human(TM) therapeutic antibody. The Company reports that the antibody neutralizes a pro-inflammatory molecule known as interleukin-6 (IL-6). Agents targeting IL-6 have been effective therapy for a number of autoimmune or oncology-related diseases. Other therapeutic antibody products targeting IL-6...

WASHINGTON, May 30, 2013 /PRNewswire-USNewswire/ -- Mark J. Shlomchik, M.D., Ph.D., the new incoming Chair of Immunology at the University of Pittsburgh, has been selected as the first recipient of the Lupus Insight Prize. The first-of-a-kind award provides $200,000 for use in innovative research on lupus, an unpredictable and sometimes fatal autoimmune disease that affects an estimated 1.5 million Americans. (Logo: http://photos.prnewswire.com/prnh/20121113/DC11393LOGO ) The...

New research by scientists at the Vitiligo Research Foundation now shows that established immunomodulator drugs such as Sodium oxodihydroacridinylacetate may be effective in stopping vitiligo, a chronic autoimmune skin disease which affects nearly 100 million people worldwide. New York City, New York (PRWEB) May 25, 2013 Researchers have been increasingly enthusiastic about harnessing the body’s own immune system to fight cancer and other diseases, and new research now shows that...